Goldman Sachs Group »

Acumen Pharmaceuticals shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Acumen Pharmaceuticals (ABOS) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Acumen Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acumen Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acumen Pharmaceuticals by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $441k 115k 3.84
2023-09-30 $238k 57k 4.15
2023-06-30 $65k 14k 4.81
2023-03-31 $172k 42k 4.06
2022-12-31 $92k 17k 5.40
2022-06-30 $131k 28k 4.70
2022-03-31 $1.3M 334k 3.91
2021-12-31 $2.2M 323k 6.76
2021-09-30 $946k 64k 14.87